However, some carcinomas remain resistant to TRAIL-mediated cell death by regulating apoptosis-related proteins, such as death receptors (DR4 and DR5) and anti-apoptotic proteins (IAPs, FLIP, and Mcl-1) [16]. This evidence concerns the gene MCL1 and carcinoma.